SEBORCYN

Serial Number 87000609
606

Registration Progress

Application Filed
Apr 14, 2016
Under Examination
Nov 1, 2016
Approved for Publication
Sep 6, 2016
Published for Opposition
Sep 6, 2016
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: SEBORCYN
Previous Owner: SONOMA PHARMACEUTICALS, INC.
Classes: 005

Trademark Image

SEBORCYN

Basic Information

Serial Number
87000609
Filing Date
April 14, 2016
Published for Opposition
September 6, 2016
Abandonment Date
June 5, 2017
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 5, 2017
Classes
005

Rights Holder

SONOMA PHARMACEUTICALS, INC.

03
Address
1129 NORTH MCDOWELL BLVD.
PETALUMA, CA 94954

Ownership History

Oculus Innovative Sciences Inc.

Original Applicant
03
Petaluma, CA

Oculus Innovative Sciences Inc.

Owner at Publication
03
Petaluma, CA

SONOMA PHARMACEUTICALS, INC.

New Owner After Publication #1
03
PETALUMA, CA

Legal Representation

Attorney
Anne E. Naffziger

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

11 events
Date Code Type Description Documents
Jun 5, 2017 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jun 5, 2017 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 26, 2017 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 1, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 6, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 6, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 17, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 29, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 29, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 19, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 18, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical topical skin application to manage, relieve and treat the symptoms associated with seborrhea skin conditions
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005